StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
410
This month
15
This week
3
This year
15
Today
1
Yesterday
3
Publishing Date
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
4
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 01
3
2022 - 02 - 23
2
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Sector
Commercial services
7
Communications
2
Consumer non-durables
3
Consumer services
1
Distribution services
1
Electronic technology
6
Energy minerals
1
Finance
4
Finance and insurance
1
Health services
9
Health technology
410
Industrial services
2
Manufacturing
138
Mining, quarrying, and oil and gas extraction
1
N/a
13
Non-energy minerals
1
Process industries
6
Producer manufacturing
8
Professional, scientific, and technical services
4
Retail trade
1
Tags
Alliances
20
America
15
Antibody
15
Application
5
Approval
5
Biotech
19
Breast cancer
13
Cancer
94
Cel
5
China
7
Clinical-trials-phase-iii
9
Collaboration
12
Covid
7
Covid-19
8
Diabetes
12
Diagnostic
10
Diagnostics
9
Disease
26
Drug
58
Drug delivery
12
Earnings
5
Enhertu
14
Europe
8
Events
7
Expected
8
Fda
5
Financial results
9
For
33
Global
39
Growing
13
Growth
64
Immunotherapy
6
Initiated
6
Iot
8
License
10
Liver
15
Lung
8
Lung cancer
10
Market
116
N/a
312
Partnership
5
People
8
Pharma
6
Phase 3
7
Positive
9
Potential
5
Regulatory
6
Report
48
Research
42
Respiratory
7
Results
20
Review
6
Risk
5
System
7
Test
6
Therapeutics
38
Therapy
20
Treatment
29
Trial
26
Vaccine
19
Entities
3m company
634
Abb ltd
872
Abbott laboratories
1024
Abbvie inc.
638
Accenture plc
354
Alphabet inc.
530
Amgen inc.
478
Apple inc.
689
Arcelormittal
345
Arrival
2435
Astrazeneca plc
410
Becton, dickinson and company
558
Bnp paribas
978
Boston scientific corporation
395
Bristol-myers squibb company
443
Cisco systems, inc.
600
Danaher corporation
484
Dow inc.
373
Eli lilly and company
1127
Ericsson
1026
Express, inc.
394
Extreme networks, inc.
479
First bank
399
Firstenergy corp.
345
Ford motor company
380
Gartner, inc.
334
General electric company
648
Gilead sciences, inc.
349
Glaxosmithkline plc
602
Honeywell international inc.
1080
Hubspot, inc.
1010
Intel corporation
618
International business machines corporation
421
Johnson & johnson
2886
Kering
596
Koninklijke philips n.v.
617
Lithium corp
528
Live nation entertainment, inc.
467
Lockheed martin corporation
374
Medtronic plc
872
Microsoft corporation
838
Morgan stanley
2607
Nokia corp
461
Nokia corporation
478
Northrop grumman corporation
383
Novartis ag
731
Novo nordisk a/s
399
Ooma, inc.
392
Oracle corporation
776
Orange
3474
Panasonic corp
399
Pfizer, inc.
506
Sanofi
2660
Sap se
933
Snowflake inc.
519
Teva pharmaceutical industries ltd
361
Thermo fisher scientific inc
933
Total se
987
Verizon communications inc.
640
X financial
363
Symbols
A
3
ABBV
47
ABT
47
ADAP
4
ALKS
4
ALPMF
19
ALPMY
19
ALXN
8
AMGN
56
ARTL
9
ATR
4
ATXI
5
AVEO
5
AZN
410
AZNCF
234
BAX
10
BDX
4
BHC
7
BIIB
11
BMY
36
BNTX
4
BSX
5
CGEN
3
CMXHF
5
CSLLY
5
DERM
3
ENDP
6
FBIO
20
FGEN
4
GILD
8
GLAXF
92
GLPG
6
GLPGF
6
GNPX
4
GSK
125
HCM
10
IPHYF
4
JNJ
82
LLY
61
MDT
9
MMM
8
MRNA
5
MTLHF
4
MTLHY
4
MYL
10
NBIX
4
NVAX
4
NVO
18
NVS
118
NVSEF
91
PFE
33
PHG
7
PODD
4
SNY
136
SNYNF
99
TAK
16
TEVA
5
TEVJF
38
TMO
8
VTRS
15
Exchanges
Amex
6
Lse
109
Nasdaq
410
Nyse
248
Tsx
1
Crawled Date
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 03 - 01
2
2022 - 02 - 23
2
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2022 - 01 - 21
2
2022 - 01 - 05
2
2021 - 12 - 16
2
2021 - 12 - 14
2
2021 - 11 - 24
3
2021 - 11 - 03
2
2021 - 10 - 07
2
2021 - 10 - 06
2
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 19
2
2021 - 08 - 12
4
2021 - 08 - 06
2
2021 - 08 - 05
6
2021 - 07 - 28
3
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 27
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 31
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
2021 - 01 - 30
2
Crawled Time
00:00
4
00:20
2
01:00
5
01:12
1
02:00
7
03:00
10
03:10
1
04:00
8
04:09
1
04:20
2
05:00
3
06:00
10
07:00
11
08:00
9
09:00
14
09:07
1
10:00
9
11:00
25
12:00
25
12:15
2
12:20
6
12:30
4
13:00
17
13:02
1
13:15
5
13:20
7
13:30
6
13:37
1
14:00
22
14:15
3
14:20
3
14:30
1
15:00
20
15:15
3
15:20
7
15:30
2
16:00
27
17:00
26
18:00
20
18:12
1
19:00
21
19:11
1
20:00
18
20:20
1
21:00
18
21:03
1
22:00
9
22:10
1
23:00
6
23:05
1
23:09
1
Source
investor.aveooncology.com
2
ir.chemocentryx.com
1
www.biospace.com
98
www.chi-med.com
2
www.globenewswire.com
43
www.prnewswire.com
263
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astrazeneca plc
save search
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published:
2023-01-31
(Crawled : 12:20)
- prnewswire.com
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
0.0%
|
O:
-3.75%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
0.0%
|
O:
-1.87%
H:
0.0%
C:
0.0%
growth
Global Gastrointestinal Therapeutics Market Report 2022: Sector to Reach $45.9 Billion by 2028 at a 3.8% CAGR
Published:
2023-01-30
(Crawled : 17:00)
- prnewswire.com
TAK
|
News
|
$15.82
-0.44%
710K
|
Health Technology
|
-0.31%
|
O:
-0.31%
H:
0.0%
C:
0.0%
PFE
|
News
|
$43.69
0.32%
19M
|
Health Technology
|
-0.79%
|
O:
-0.79%
H:
0.0%
C:
0.0%
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
-0.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.25
-0.51%
1.2M
|
Health Technology
|
-0.59%
|
O:
-0.59%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
1.45%
|
O:
1.45%
H:
0.0%
C:
0.0%
global
report
gastrointestinal
therapeutics
market
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
Published:
2023-01-30
(Crawled : 14:00)
- biospace.com/
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
1.45%
|
O:
1.45%
H:
0.0%
C:
0.0%
lung
trial
cancer
initiated
GERD market size to increase by USD 908.49 million; North America to account for 38% of market growth - Technavio
Published:
2023-01-25
(Crawled : 03:00)
- prnewswire.com
GSK
|
News
|
$35.385
0.76%
1.8M
|
Health Technology
|
2.05%
|
O:
0.26%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.25
-0.51%
1.2M
|
Health Technology
|
-2.64%
|
O:
-2.56%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
0.35%
|
O:
-0.2%
H:
0.0%
C:
0.0%
america
for
growth
market
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Published:
2023-01-23
(Crawled : 13:00)
- biospace.com/
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-4.68%
|
O:
-1.28%
H:
0.57%
C:
-1.6%
acquire
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published:
2023-01-18
(Crawled : 18:00)
- prnewswire.com
VTRS
|
News
|
$12.045
0.88%
2.5M
|
Health Technology
|
-0.08%
|
O:
-0.17%
H:
0.25%
C:
-2.96%
TMO
|
News
|
$562.66
-0.29%
420K
|
Health Technology
|
-3.18%
|
O:
0.56%
H:
0.97%
C:
-1.87%
NVO
|
News
|
$137.59
-1.06%
410K
|
Health Technology
|
-1.04%
|
O:
0.57%
H:
0.84%
C:
-0.01%
NVS
|
News
|
$89.81
0.19%
740K
|
Health Technology
|
-3.21%
|
O:
0.08%
H:
0.01%
C:
-1.16%
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
-3.56%
|
O:
-1.47%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.385
0.76%
1.8M
|
Health Technology
|
0.15%
|
O:
-0.03%
H:
0.17%
C:
-1.01%
LLY
|
$342.22
0.51%
520K
|
Health Technology
|
-4.23%
|
O:
-1.13%
H:
0.0%
C:
0.0%
ABT
|
News
|
$109.25
-0.51%
1.2M
|
Health Technology
|
-3.03%
|
O:
-0.16%
H:
0.33%
C:
-1.5%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
-1.73%
|
O:
-0.14%
H:
0.0%
C:
0.0%
BIIB
A
|
$289.86
1.37%
140K
|
Health Technology
|
-0.46%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-6.22%
|
O:
1.36%
H:
0.33%
C:
-1.13%
AMGN
|
News
|
$251.27
-0.13%
560K
|
Health Technology
|
-5.97%
|
O:
0.0%
H:
0.41%
C:
-1.87%
for
therapy
growth
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
Published:
2023-01-18
(Crawled : 15:00)
- globenewswire.com
HCM
|
News
|
$17.62
-0.4%
150K
|
Health Technology
|
13.15%
|
O:
1.32%
H:
4.49%
C:
1.01%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-6.22%
|
O:
1.36%
H:
0.33%
C:
-1.13%
orpathys
drug
for
agreement
china
Press release Biocartis Group NV: BIOCARTIS MEETS 2022 KEY OBJECTIVES
Published:
2023-01-17
(Crawled : 17:00)
- globenewswire.com
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-6.58%
|
O:
0.86%
H:
0.03%
C:
-1.23%
group
The Worldwide Lysosomal Disease Treatment Industry is Expected to Reach $11 Billion by 2028
Published:
2023-01-13
(Crawled : 13:00)
- prnewswire.com
TAK
|
News
|
$15.82
-0.44%
710K
|
Health Technology
|
2.21%
|
O:
0.96%
H:
0.0%
C:
0.0%
PFE
|
News
|
$43.69
0.32%
19M
|
Health Technology
|
-7.3%
|
O:
1.08%
H:
0.0%
C:
0.0%
NVS
|
News
|
$89.81
0.19%
740K
|
Health Technology
|
0.12%
|
O:
0.8%
H:
0.0%
C:
0.0%
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
-3.44%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
|
$342.22
0.51%
520K
|
Health Technology
|
-3.43%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
1.25%
|
O:
1.89%
H:
0.0%
C:
0.0%
BMRN
M
|
$115.37
0.58%
160K
|
Health Technology
|
5.64%
|
O:
2.13%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-4.98%
|
O:
1.7%
H:
0.0%
C:
0.0%
treatment
disease
expected
Global Head And Neck Cancer Therapeutics Market Report 2022: Sector to Reach $2.5 Billion by 2028 at a 12.3% CAGR
Published:
2023-01-12
(Crawled : 22:00)
- prnewswire.com
TAK
|
News
|
$15.82
-0.44%
710K
|
Health Technology
|
2.21%
|
O:
0.96%
H:
0.0%
C:
0.0%
LLY
|
$342.22
0.51%
520K
|
Health Technology
|
-3.43%
|
O:
0.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
1.25%
|
O:
1.89%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-4.98%
|
O:
1.7%
H:
0.0%
C:
0.0%
global
report
therapeutics
cancer
market
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published:
2023-01-10
(Crawled : 21:00)
- prnewswire.com
AZNCF
|
News
|
$129.36
0
|
Health Technology
|
-9.25%
|
O:
-1.28%
H:
0.0%
C:
-0.82%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-7.35%
|
O:
-0.33%
H:
0.13%
C:
-1.28%
covid-19
research
global
report
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published:
2023-01-09
(Crawled : 10:00)
- prnewswire.com
GSK
|
News
|
$35.385
0.76%
1.8M
|
Health Technology
|
3.67%
|
O:
1.76%
H:
0.0%
C:
0.0%
LLY
|
$342.22
0.51%
520K
|
Health Technology
|
-3.85%
|
O:
1.12%
H:
0.27%
C:
-3.89%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
2.55%
|
O:
1.82%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-5.07%
|
O:
1.67%
H:
0.86%
C:
-0.21%
research
market
Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer
Published:
2023-01-05
(Crawled : 16:00)
- biospace.com/
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-5.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
lung
for
biomarker
cancer
study
Genomic Vision announces successful beta testing of FiberSmart®
Published:
2023-01-05
(Crawled : 07:00)
- globenewswire.com
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-5.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
fibersmart
genomic
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published:
2023-01-04
(Crawled : 23:00)
- prnewswire.com
NVS
|
News
|
$89.81
0.19%
740K
|
Health Technology
|
-1.81%
|
O:
-0.84%
H:
0.0%
C:
0.0%
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
-6.02%
|
O:
0.22%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
-0.57%
|
O:
-3.07%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-5.93%
|
O:
-2.09%
H:
0.0%
C:
0.0%
treatment
patent
global
report
growing
diabetes
growth
market
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
NVS
|
News
|
$89.81
0.19%
740K
|
Health Technology
|
-1.55%
|
O:
-0.03%
H:
0.0%
C:
0.0%
GSK
|
News
|
$35.385
0.76%
1.8M
|
Health Technology
|
1.38%
|
O:
-0.14%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
0.87%
|
O:
-0.39%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-2.58%
|
O:
-0.5%
H:
0.0%
C:
0.0%
global
report
sanofi
market
Global Precision Cancer Therapeutics Market Report 2022: Overview of Disease Epidemiology, Leading Product sales, Market Estimates and Forecasts, and Competitive Summary of Leading Providers
Published:
2022-12-30
(Crawled : 15:00)
- prnewswire.com
PFE
|
News
|
$43.69
0.32%
19M
|
Health Technology
|
-14.63%
|
O:
0.02%
H:
0.0%
C:
0.0%
NVS
|
News
|
$89.81
0.19%
740K
|
Health Technology
|
-1.55%
|
O:
-0.03%
H:
0.0%
C:
0.0%
JNJ
|
News
6 d
|
$161.43
-0.35%
3.3M
|
Health Technology
|
-5.3%
|
O:
-0.01%
H:
0.0%
C:
0.0%
BMY
|
$72.0
-0.04%
1.5M
|
Health Technology
|
1.11%
|
O:
0.13%
H:
0.0%
C:
0.0%
SNY
|
News
|
$48.85
0.58%
260K
|
Health Technology
|
0.87%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GILD
|
News
F
|
$83.38
0.04%
2M
|
Health Technology
|
-1.78%
|
O:
-0.12%
H:
0.0%
C:
0.0%
EXEL
M
|
$17.575
1.06%
390K
|
Health Technology
|
13.09%
|
O:
0.03%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-2.58%
|
O:
-0.5%
H:
0.0%
C:
0.0%
global
disease
report
therapeutics
cancer
market
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Need of Potential Treatments to Improve Quality of Life Drives Sector
Published:
2022-12-22
(Crawled : 17:00)
- prnewswire.com
JAZZ
|
$155.67
1.24%
38K
|
Health Technology
|
-2.42%
|
O:
0.91%
H:
0.0%
C:
0.0%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-2.3%
|
O:
-0.12%
H:
0.0%
C:
0.0%
lung
global
report
life
potential
cancer
market
Fortress Biotech Appoints Lucy Lu, M.D., to its Board of Directors
Published:
2022-12-19
(Crawled : 13:20)
- globenewswire.com
AZNCF
|
News
|
$129.36
0
|
Health Technology
|
-5.31%
|
O:
-1.12%
H:
0.06%
C:
0.06%
VERU
|
News
|
$5.8
4.13%
780K
|
Health Technology
|
15.96%
|
O:
-1.28%
H:
0.4%
C:
-3.99%
FBIO
|
$0.9
-3.23%
110K
|
Health Technology
|
51.28%
|
O:
-2.44%
H:
0.0%
C:
0.0%
ATXI
|
$1.34
1.52%
61K
|
Health Technology
|
11.74%
|
O:
-0.4%
H:
1.63%
C:
-6.5%
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-2.57%
|
O:
-0.29%
H:
0.01%
C:
-0.62%
biotech
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
Published:
2022-12-16
(Crawled : 13:00)
- biospace.com/
AZN
|
News
|
$65.14
-1.06%
1.6M
|
Health Technology
|
-5.28%
|
O:
-2.78%
H:
0.0%
C:
0.0%
cancer
← Previous
1
2
3
4
5
6
7
8
9
…
20
21
Next →
Gainers vs Losers
87%
13%
Top 10 Gainers
MSGM
|
News
P
338983
|
$22.57
758.18%
28M
|
ATCX
|
$12.04
120.11%
3.4M
|
Finance
CNTX
|
News
|
$1.14
66.91%
56M
|
Health Technology
HYPR
|
$1.33
52.86%
13M
|
Manufacturing
FOXO
|
$1.19
27.94%
20M
|
PRDS
|
News
|
$2.24
24.44%
110K
|
Professional, Scientific, and T...
DPRO
|
News
|
$2.05
22.75%
1.4M
|
ERYP
|
$0.8631
19.88%
260K
|
Health Technology
SOBR
4
|
$1.33
19.82%
9.6M
|
Information
SPPI
|
News
|
$0.6358
17.48%
3.1M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.